Protein restriction for diabetic renal disease

Area of Science:

• Nephrology
• Endocrinology
• Dietary Science

Background:

• Diabetic renal disease (diabetic nephropathy) is a primary cause of end-stage renal failure.
• Progression of diabetic nephropathy may be slowed by blood pressure control and protein restriction, even if the condition is irreversible.

Purpose of the Study:

• To evaluate the impact of dietary protein restriction on the progression of diabetic nephropathy in individuals with diabetes.

Main Methods:

• Systematic review and meta-analysis of randomized controlled trials (RCTs) and before-and-after studies.
• Searched multiple databases including Cochrane Library, MEDLINE, EMBASE, and others.
• Data extraction and quality assessment performed independently by two reviewers; results pooled using a random-effects model.

Main Results:

• Twelve studies (9 RCTs, 3 before-and-after) were included. Low protein diet (LPD) showed a reduced risk of end-stage renal disease (ESRD) or death (RR 0.23).
• In type 1 diabetes, LPD did not significantly reduce the decline in glomerular filtration rate (GFR).
• In type 2 diabetes, results were inconsistent, with one trial showing a small, insignificant improvement and another showing no difference.

Conclusions:

• Reducing protein intake may offer a slight, though not statistically significant, slowing of renal failure progression.
• Further long-term research is required to establish optimal protein intake levels, compliance, and efficacy in diverse patient groups.
• Consideration of a trial period of protein restriction for individual patient response is suggested.